Area of research
Otorhinolaryngology · Cancer Research
Research interest
Research interests include Cancer research, Doxorubicin, Multiple drug resistance, Cancer cell, Ovarian cancer, and DNA damage.
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
<i>miR-30a</i> can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation